Appeal No. 2002-1644 Page 6 Application No. 08/602,498 According to Gardner (id., paragraph 10), the product was sold to the dairyman because, [i]f a test product is provided to the dairyman at no cost, or at a substantially reduced cost compared to the product the dairyman is currently using, the dairyman will have a tendency to overstate the effectiveness of the test product in an effort to obtain a lower cost or free test product. If the test product is provided at a price or is substantially near the projected retail price, an unbiased evaluation of the product from the dairyman is usually obtained. As set forth in EZ Dock Inc. v. Schafer Systems Inc., 276 F. 3d 1347, 1352, 61 USPQ2d 1289, 1292 (CAFC 2002), citations omitted, an inventor who seeks to perfect his discovery may conduct extensive testing without losing his right to obtain a patent for his invention – even if such testing occurs in the public eye. The law has long recognized the distinction between inventions put to experimental use and products sold commercially. … Experimentation evidence includes “tests needed to convince [the inventor] that the invention is capable of performing its intended purpose in its intended environment.” Here as in EZ Dock, 276 F. 3d at 1352, 61 USPQ2d at 1292-93, the evidence demonstrates that the full market price was not paid for the product during testing. Gardner declares (Gardner Declaration, paragraph 12) that he “regularly monitored the efficacy of DX-206 via personal visits and phone conversations to … [his] clients over at least a period of several months” and reported any problems to Babson. As set forth in EZ Dock, 276 F.3d at 1353, 61 USPQ2d at 1293 (citations omitted), “this court has often consulted evidence of monitoring to discern the distinction between experimental and commercial sales.” Based on the evidence on this record, it is our opinion, that the inventors were working to detect and correct flaws in their invention during the field trials. Cf. EZ Dock, 276 F.3d at 1353, 61 USPQ2d at 1293. Accordingly, in our opinionPage: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 NextLast modified: November 3, 2007